Phase IV Clinical Study Evaluating The Efficacy of Chemoradiotherapy Following Neoadjuvant Treatment With Docetaxel and Cisplatin in Indifferentiated and Non-Keratinized Squamous Cell Carcinoma of Nasopharynx.

Trial Profile

Phase IV Clinical Study Evaluating The Efficacy of Chemoradiotherapy Following Neoadjuvant Treatment With Docetaxel and Cisplatin in Indifferentiated and Non-Keratinized Squamous Cell Carcinoma of Nasopharynx.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Acronyms Tax-Nazo
  • Sponsors Sanofi
  • Most Recent Events

    • 22 May 2009 Primary endpoint changed from disease free survival to complete clinical response rate as reported by ClinicalTrials.gov.
    • 09 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top